STOCK TITAN

Mainz Biomed N.V. (MYNZ) Stock News, Feb-Apr 2024

MYNZ NASDAQ

Ticker history: MYNZ became QUCY (Quantum Cyber N.V.) on .

Mainz Biomed N.V. has reported developments tied to molecular genetics diagnostics for early cancer detection and a later corporate transition to the Quantum Cyber name and QUCY ticker. Its company updates have centered on ColoAlert, a non-invasive colorectal cancer screening test marketed in Europe, and PancAlert, an early-stage pancreatic cancer screening candidate using PCR-based multiplex detection of molecular-genetic biomarkers in blood and stool samples.

Recurring news themes include clinical-study and conference disclosures for colorectal and pancreatic cancer detection, commercial distribution and digital-health partnerships, financing activity, strategic updates, board governance changes, and Nasdaq ticker matters.

-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.33%
Tags
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.00%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.85%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.94%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.49%
Tags
partnership
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.70%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.93%
Tags
partnership
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.97%
Tags
partnership
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.26%
Tags
none

FAQ

What is the current stock price of Mainz Biomed (MYNZ)?

Mainz Biomed (MYNZ) last closed at $0.8441. The company now trades as QUCY.